🔎 Trials Near Me

Nyumbani › Multiple Myeloma › New Jersey

Majaribio ya kliniki ya Multiple Myeloma katika jimbo la New Jersey

Masomo 38 ya Multiple Myeloma yanatafuta washiriki katika vituo vya jimbo la New Jersey.

Miji katika jimbo la New Jersey

Maandishi rasmi ya utafiti (Kiingereza)

A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
InaajiriHatua 2
Umri 60 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT06679829

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

  • Astera Cancer Care, East Brunswick
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT07518186

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

  • Hackensack University Medical Center, Hackensack
  • Rutgers Cancer Institute of New Jersey, New Brunswick
InaajiriHatua 4
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT05201781

Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma

  • Hackensack Meridian Health - John Theurer Cancer Center, Hackensack
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT03909412

A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma

  • John Theurer Cancer Center, Hackensack
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT04661137

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

  • Hackensack Meridian Health, Hackensack
  • Carol G Simon Cancer Center, Morristown
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT07648264

Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 15 Sep 2026 · NCT06976476

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

  • Rutgers Cancer Institute of New Jersey, New Brunswick
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT06297226

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

  • John Theurer Cancer Center, Hackensack University Medical Center, Hackensack
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Ago 2026 · NCT07075185

A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma

  • Research Site, Hackensack
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 27 Ago 2026 · NCT07681596

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

  • MSK Basking Ridge, Basking Ridge
  • MSK Monmouth, Middletown
  • MSK Bergen, Montvale
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 24 Ago 2026 · NCT05020236

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

  • Jefferson Cherry Hill Hospital, Cherry Hill
  • Sidney Kimmel Cancer Center Washington Township, Sewell
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 19 Ago 2026 · NCT04566328

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

  • Hackensack University Medical Center, Hackensack
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Ago 2026 · NCT05651932

A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 17 Ago 2026 · NCT07105059

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

  • Research Site, East Brunswick
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Ago 2026 · NCT07764978

A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Consent only), Middletown
  • Memorial Sloan Kettering Bergen (Consent Only), Montvale
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 6 Ago 2026 · NCT07249528

Mosaic Trial for Stem Cell Transplant Recipients

  • Hackensack Meridian Health, Nutley
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 3 Ago 2026 · NCT06960993

A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Jul 2026 · NCT07099391

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Jul 2026 · NCT06121843

A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 6 Jul 2026 · NCT06083922

A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Jun 2026 · NCT07454382

Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization

  • Rutgers Cancer Institute of New Jersey, New Brunswick
  • RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Brunswick
InaajiriHatua ya kwanza ya awali
Umri 18 na zaidi · Jinsia zote · Imesasishwa 29 Mei 2026 · NCT04211259

A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

  • Rutgers Cancer Institute of New Jersey, New Brunswick
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 13 Mei 2026 · NCT05828511

A Dietary Study for People With Multiple Myeloma

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 5 Mei 2026 · NCT07226609

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

  • Atlantic Health, Morristown
  • Rutgers Cancer Institute of New Jersey, New Brunswick
InaajiriHatua 1/2
Umri 12 na zaidi · Jinsia zote · Imesasishwa 24 Mac 2026 · NCT04988555

A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 4 Mac 2026 · NCT06066346

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Memorial Sloan Kettering Monmouth, Middletown
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri wote · Jinsia zote · Imesasishwa 23 Jan 2026 · NCT00582621

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 13 Nov 2025 · NCT06055894

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

  • Hackensack Meridian John Theurer Cancer Center, Hackensack
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2025 · NCT05722418

A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma

  • John Theurer Cancer Center at Hackensack UMC, Hackensack
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 5 Sep 2025 · NCT05372354

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.